Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    24552317 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status
Conditions: Glioblastoma Multiforme;   Primary Brain Tumor
Interventions: Drug: Temozolomide;   Drug: Bevacizumab
2 Active, not recruiting
Has Results
Temozolomide (TMZ) and Radiation Therapy (RT) With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (GBM)
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Cognitive Side Effects of Cancer Therapy
Interventions: Radiation: Radiation therapy pre-randomization;   Biological: Bevacizumab;   Drug: Placebo;   Drug: Temozolomide pre-randomization;   Drug: Temozolomide post-randomization;   Radiation: Radiation therapy post-randomization

Indicates status has not been verified in more than two years